Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125389021 | 12538902 | 1 | I | 201302 | 20160624 | 20160708 | 20160708 | EXP | GB-TEVA-672099ACC | TEVA | 48.00 | YR | F | Y | 0.00000 | 20160708 | MD | GB | GB |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125389021 | 12538902 | 1 | PS | PACLITAXEL. | PACLITAXEL | 1 | Unknown | UNK, QWK | U | U | 75297 | /wk | |||||||
| 125389021 | 12538902 | 2 | SS | PROLIA | DENOSUMAB | 1 | Unknown | UNK | U | 0 | |||||||||
| 125389021 | 12538902 | 3 | C | CAPECITABINE. | CAPECITABINE | 1 | 0 | ||||||||||||
| 125389021 | 12538902 | 4 | C | EVEROLIMUS | EVEROLIMUS | 1 | 0 | ||||||||||||
| 125389021 | 12538902 | 5 | C | EXEMESTANE. | EXEMESTANE | 1 | 0 | ||||||||||||
| 125389021 | 12538902 | 6 | C | LETROZOLE. | LETROZOLE | 1 | 0 | ||||||||||||
| 125389021 | 12538902 | 7 | C | TAMOXIFEN | TAMOXIFEN | 1 | 0 | ||||||||||||
| 125389021 | 12538902 | 8 | C | ZOLADEX | GOSERELIN ACETATE | 1 | 0 | ||||||||||||
| 125389021 | 12538902 | 9 | C | ZOLEDRONIC ACID | ZOLEDRONIC ACID | 1 | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125389021 | 12538902 | 1 | Product used for unknown indication |
| 125389021 | 12538902 | 2 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125389021 | 12538902 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125389021 | 12538902 | Bone disorder | |
| 125389021 | 12538902 | Breast cancer female | |
| 125389021 | 12538902 | Cough | |
| 125389021 | 12538902 | Disease progression | |
| 125389021 | 12538902 | Lymphadenopathy mediastinal | |
| 125389021 | 12538902 | Metastases to bone | |
| 125389021 | 12538902 | Metastases to lymph nodes | |
| 125389021 | 12538902 | Pericardial effusion | |
| 125389021 | 12538902 | Pleural effusion | |
| 125389021 | 12538902 | Pneumonitis |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |